Drug intelligence / Profile preview

autologous extrahepatic cholangiocyte organoids

Development stage
Phase 2
Lead developer
University of Cambridge
Modality
Stem Cell Therapies → Cell Therapies
Administration
Intrabiliary, Surgical Implantation
01

Overview

Autologous extrahepatic cholangiocyte organoids are a personalized regenerative medicine product designed to repair or replace damaged bile ducts. These organoids are generated by isolating primary cholangiocytes from the patient’s own biliary tissue (often through bile samples or biopsies), expanding them in a three-dimensional culture system to form organotypic structures, and subsequently transplanting them back into the patient. The mechanism involves the integration of these organoids into the host biliary epithelium, where they provide functional reconstruction of the ductal lining, restoring bile transport and preventing fibrosis. This approach is particularly targeted at conditions like primary sclerosing cholangitis and biliary atresia, aiming to provide an alternative to liver transplantation by directly repairing the extrahepatic biliary system.

Other names
Autologous biliary organoidsExtrahepatic bile duct organoidsCholangiocyte organoids

Beyond the preview

Go deeper on autologous extrahepatic cholangiocyte organoids.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on autologous extrahepatic cholangiocyte organoids.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call